Trials / Sponsors / OncoNano Medicine, Inc.
OncoNano Medicine, Inc.
Industry · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma | Phase 1 | 2023-10-13 |
| Completed | A Study to Evaluate Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Lung Mal Lung Cancer | Phase 2 | 2022-04-13 |
| Completed | A Study to Evaluate ONM100, an Intraoperative Fluor Imaging Agent for the Detection of Peri Mets Peritoneal Carcinomatosis | Phase 2 | 2021-11-30 |
| Completed | A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer Breast Cancer, Head and Neck Squamous Cell Carcinoma, Colorectal Cancer | Phase 2 | 2019-08-09 |